Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis

BACKGROUND: The systemic immune-inflammation index (SII) is a novel biomarker to predict the prognosis of some malignant tumors based on neutrophil, platelet, and lymphocyte counts. Evidence is scarce about the prognostic value of SII for prostate cancer patients. This systematic review and meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Linghao, Yang, Yujia, Hu, Xu, Zhang, Ruohan, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898902/
https://www.ncbi.nlm.nih.gov/pubmed/36739407
http://dx.doi.org/10.1186/s12967-023-03924-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898902/
https://www.ncbi.nlm.nih.gov/pubmed/36739407
http://dx.doi.org/10.1186/s12967-023-03924-y

Ejemplares similares